U.S. Glaucoma Surgery Devices Market Size & Outlook
U.S. glaucoma surgery devices market, 2018-2030 (US$M)
Related Markets
U.S. glaucoma surgery devices market highlights
- The U.S. glaucoma surgery devices market generated a revenue of USD 448.1 million in 2023 and is expected to reach USD 608.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.5% from 2024 to 2030.
- In terms of segment, glaucoma drainage device was the largest revenue generating product in 2023.
- Glaucoma drainage device is the most lucrative product segment registering the fastest growth during the forecast period.
Glaucoma surgery devices market data book summary
| Market revenue in 2023 | USD 448.1 million |
| Market revenue in 2030 | USD 608.1 million |
| Growth rate | 4.5% (CAGR from 2023 to 2030) |
| Largest segment | Glaucoma drainage device |
| Fastest growing segment | Glaucoma drainage device |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Punches, USC maker, USC planner, USC shaver, Forceps, Algerbrush, Probes, Diamond knives, Glaucoma drainage device, Laser system |
| Key market players worldwide | Alcon Inc, Glaukos Corp, Johnson & Johnson, AbbVie Inc, Carl Zeiss Meditec AG, Lumenis, Ziemer Ophthalmic Systems, IRIDEX Corp, Corza Health, Katalyst Surgical, Altomed |
Other key industry trends
- In terms of revenue, U.S. accounted for 27.0% of the global glaucoma surgery devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. glaucoma surgery devices market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 248.7 million by 2030.
Glaucoma drainage device was the largest segment with a revenue share of 27.78% in 2023. Horizon Databook has segmented the U.S. glaucoma surgery devices market based on punches, usc maker, usc planner, usc shaver, forceps, algerbrush, probes, diamond knives, glaucoma drainage device, laser system covering the revenue growth of each sub-segment from 2018 to 2030.
The favorable reimbursement scenario provides access to healthcare services to a large portion of the population. Subsequently, it creates a demand for cost-effective and efficient diabetes management devices. This also increases the need for cost-effective treatment and the integration of digital health in the care delivery system.
Hence, many companies seek U.S. FDA approval to launch their products in the U.S. market. For instance, in February 2023, Regeneron received FDA approval for Eylea to treat diabetic retinopathy in infants.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Glaucoma Surgery Devices Market Scope
Glaucoma Surgery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. glaucoma surgery devices market size, by product, 2018-2030 (US$M)
U.S. Glaucoma Surgery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
